AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study

被引：35

作者：

Dummer, R.

Robert, C.

Chapman, P. B.

Sosman, J. A.

Middleton, M.

Bastholt, L.

Kemsley, K.

Cantarini, M. V.

Morris, C.

Kirkwood, J. M.

机构：

[1] Univ Zurich Hosp, CH-8091 Zurich, Switzerland

[2] Inst Gustave Roussy, Villejuif, France

[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[4] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[5] Churchill Hosp, Oxford OX3 7LJ, England

[6] Odense Univ Hosp, DK-5000 Odense, Denmark

[7] AstraZeneca, Macclesfield, Cheshire, England

[8] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA

来源：

关键词：

D O I：

10.1200/jco.2008.26.15_suppl.9033

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

9033

引用

页数：1